Insider Stock Trading History of Staab Thomas R Ii


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Staab Thomas R Ii since year 2005. The trader's CIK number is 1230708. At the time of this reporting, Staab Thomas R Ii is the Senior Vice President and CFO of Biocryst Pharmaceuticals Inc . (stock ticker symbol BCRX). See this page for all insider trading activities at Biocryst Pharmaceuticals Inc .

Note that in the past STAAB THOMAS R II also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Staab Thomas R Ii since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-05-22 BCRX Biocryst Pharmaceuticals Inc Option Ex 7,750 4.73 36,657
2017-03-20 BCRX Biocryst Pharmaceuticals Inc Option Ex 3,250 3.78 12,285
2017-03-20 BCRX Biocryst Pharmaceuticals Inc Sale 3,250 9.20 29,899
2017-03-16 BCRX Biocryst Pharmaceuticals Inc Option Ex 36,455 2.60 94,783
2017-03-10 BCRX Biocryst Pharmaceuticals Inc Sale 3,250 9.06 29,445
2017-03-10 BCRX Biocryst Pharmaceuticals Inc Option Ex 3,250 3.78 12,285
2017-03-08 BCRX Biocryst Pharmaceuticals Inc Option Ex 6,500 3.78 24,570
2017-03-08 BCRX Biocryst Pharmaceuticals Inc Sale 6,500 8.43 54,762
2017-03-06 BCRX Biocryst Pharmaceuticals Inc Sale 3,250 7.90 25,675
2017-03-06 BCRX Biocryst Pharmaceuticals Inc Option Ex 3,250 3.78 12,285
2016-12-19 BCRX Biocryst Pharmaceuticals Inc Option Ex 3,250 3.78 12,285
2016-12-19 BCRX Biocryst Pharmaceuticals Inc Sale 3,250 7.45 24,212
2016-08-11 BCRX Biocryst Pharmaceuticals Inc Sale 1,306 5.05 6,595
2016-08-12 BCRX Biocryst Pharmaceuticals Inc Sale 4,558 5.22 23,792
2016-08-09 BCRX Biocryst Pharmaceuticals Inc Sale 14,577 4.43 64,576
2016-01-19 BCRX Biocryst Pharmaceuticals Inc Option Ex 15,000 2.60 39,000
2015-12-21 BCRX Biocryst Pharmaceuticals Inc Sale 3,052 10.86 33,144
2015-12-17 BCRX Biocryst Pharmaceuticals Inc Sale 3,000 10.49 31,470
2015-07-20 BCRX Biocryst Pharmaceuticals Inc Sale 3,500 16.50 57,750
2015-06-22 BCRX Biocryst Pharmaceuticals Inc Option Ex 3,750 4.73 17,737
2015-06-22 BCRX Biocryst Pharmaceuticals Inc Sale 3,750 16.00 60,000
2015-06-18 BCRX Biocryst Pharmaceuticals Inc Option Ex 6,200 3.78 23,436
2015-06-19 BCRX Biocryst Pharmaceuticals Inc Option Ex 3,175 3.78 12,001
2015-06-18 BCRX Biocryst Pharmaceuticals Inc Sale 9,700 13.92 134,994
2015-06-19 BCRX Biocryst Pharmaceuticals Inc Sale 6,675 15.00 100,125
2015-06-05 BCRX Biocryst Pharmaceuticals Inc Sale 6,000 12.75 76,500
2015-06-01 BCRX Biocryst Pharmaceuticals Inc Sale 3,000 12.00 36,000
2015-05-18 BCRX Biocryst Pharmaceuticals Inc Sale 3,000 11.00 33,000
2014-12-29 BCRX Biocryst Pharmaceuticals Inc Option Ex 9,500 3.78 35,910
2014-12-29 BCRX Biocryst Pharmaceuticals Inc Sale 9,500 12.56 119,320
2014-08-27 BCRX Biocryst Pharmaceuticals Inc Option Ex 10,000 5.45 54,500
2014-08-27 BCRX Biocryst Pharmaceuticals Inc Sale 10,000 13.58 135,800
2014-07-25 BCRX Biocryst Pharmaceuticals Inc Option Ex 26,455 3.78 99,999
2014-07-01 BCRX Biocryst Pharmaceuticals Inc Sale 3,125 13.00 40,625
2014-07-01 BCRX Biocryst Pharmaceuticals Inc Option Ex 3,125 4.73 14,781
2014-06-23 BCRX Biocryst Pharmaceuticals Inc Sale 3,125 12.49 39,031
2014-06-23 BCRX Biocryst Pharmaceuticals Inc Option Ex 3,125 4.73 14,781
2014-06-17 BCRX Biocryst Pharmaceuticals Inc Option Ex 3,125 4.73 14,781
2014-06-17 BCRX Biocryst Pharmaceuticals Inc Sale 3,125 12.00 37,500
2014-05-22 BCRX Biocryst Pharmaceuticals Inc Option Ex 17,685 3.78 66,849
2014-03-14 BCRX Biocryst Pharmaceuticals Inc Sale 3,125 11.24 35,125
2014-03-14 BCRX Biocryst Pharmaceuticals Inc Option Ex 3,125 4.73 14,781
2014-03-04 BCRX Biocryst Pharmaceuticals Inc Option Ex 3,000 4.73 14,190
2014-03-04 BCRX Biocryst Pharmaceuticals Inc Sale 3,000 12.69 38,070
2014-01-13 BCRX Biocryst Pharmaceuticals Inc Option Ex 35,225 3.78 133,150
2007-03-12 ISPH Inspire Pharmaceuticals Inc Option Ex 2,000 5.25 10,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Staab Thomas R Ii (Senior Vice President and CFO of Biocryst Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.